0001973379-24-000028.txt : 20240209 0001973379-24-000028.hdr.sgml : 20240209 20240209141738 ACCESSION NUMBER: 0001973379-24-000028 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20240209 DATE AS OF CHANGE: 20240209 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Ascendis Pharma A/S CENTRAL INDEX KEY: 0001612042 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: G7 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 001-36815 FILM NUMBER: 24613981 BUSINESS ADDRESS: STREET 1: TUBORG BOULEVARD 12 CITY: HELLERUP STATE: G7 ZIP: DK-2900 BUSINESS PHONE: 45 70 22 22 44 MAIL ADDRESS: STREET 1: TUBORG BOULEVARD 12 CITY: HELLERUP STATE: G7 ZIP: DK-2900 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: MIKKELSEN JAN MOLLER CENTRAL INDEX KEY: 0001180765 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 144 MAIL ADDRESS: STREET 1: 515 GALVESTON DR CITY: REDWOOD CITY STATE: CA ZIP: 94063 144 1 primary_doc.xml 144 0001180765 XXXXXXXX LIVE 0001612042 Ascendis Pharma A/S 001-36815 TUBORG BOULEVARD 12 HELLERUP G7 DK-2900 45 70 22 22 44 MIKKELSEN JAN MOLLER Officer CEO Ordinary Shares Citigroup Global Markets Inc.

390 Greenwich Street New York NY 10013

5483 769787.62 57707439 02/09/2024 NASDAQ Ordinary Shares 02/09/2024 From Previous Restricted Stock Vesting Ascendis Pharma A/S N 5483 02/09/2024 Services Rendered N Jan Moller Mikkelsen

c/o Tuborg Boulevard 12 Hellerup G7 DK-2900

Ordinary Shares 11/23/2023 24000 2348880.00 Under securities to be sold, the date acquired & date of payment are various dates. 02/09/2024 Conformed Signature on File